<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[RSS Feed]]></title><description><![CDATA[RSS Feed]]></description><link>http://direct.ecency.com</link><image><url>http://direct.ecency.com/logo512.png</url><title>RSS Feed</title><link>http://direct.ecency.com</link></image><generator>RSS for Node</generator><lastBuildDate>Wed, 22 Apr 2026 13:13:03 GMT</lastBuildDate><atom:link href="http://direct.ecency.com/created/lymphoblastic/rss.xml" rel="self" type="application/rss+xml"/><item><title><![CDATA[Acute Lymphoblastic Leukemia Disease Pipeline Drugs Assessment: Clinical Trails Analysis, Player Profiles, Collaborations, Key Targets, Geographic Focus, and Data Publications, 2018]]></title><description><![CDATA[Acute Lymphoblastic Leukemia Disease Pipeline Drugs Assessment: Clinical Trails Analysis, Player Profiles, Collaborations, Key Targets, Geographic Focus, and Data Publications, 2018 Acute Lymphoblastic]]></description><link>http://direct.ecency.com/acute/@jasjasmine/acute-lymphoblastic-leukemia-disease-pipeline-drugs-assessment-clinical-trails-analysis-player-profiles-collaborations-key</link><guid isPermaLink="true">http://direct.ecency.com/acute/@jasjasmine/acute-lymphoblastic-leukemia-disease-pipeline-drugs-assessment-clinical-trails-analysis-player-profiles-collaborations-key</guid><category><![CDATA[acute]]></category><dc:creator><![CDATA[jasjasmine]]></dc:creator><pubDate>Mon, 28 May 2018 12:30:06 GMT</pubDate></item><item><title><![CDATA[Global Acute Lymphoblastic Leukemia Drug Sales Market Size, Trends, Analysis, Players & Forecast by 2025]]></title><description><![CDATA[An up-to-date research report has been disclosed by Market Research Hub highlighting the title “Global Acute Lymphoblastic Leukemia Drug Sales Market Research Report 2018” which provides an outlook of]]></description><link>http://direct.ecency.com/pharmaceutical/@sumaanraina/global-acute-lymphoblastic-leukemia-drug-sales-market-size-trends-analysis-players-and-forecast-by-2025</link><guid isPermaLink="true">http://direct.ecency.com/pharmaceutical/@sumaanraina/global-acute-lymphoblastic-leukemia-drug-sales-market-size-trends-analysis-players-and-forecast-by-2025</guid><category><![CDATA[pharmaceutical]]></category><dc:creator><![CDATA[sumaanraina]]></dc:creator><pubDate>Fri, 16 Mar 2018 07:37:30 GMT</pubDate></item><item><title><![CDATA[FDA Approves First Gene Therapy for Pediatric Leukemia]]></title><description><![CDATA[The first gene therapy treatment approved by the FDA and available in the United States is tisagenlecleucel for pediatric and young adult patients with leukemia. Tisagenlecleucel is a treatment for relapsed]]></description><link>http://direct.ecency.com/health/@etcmike/fda-approves-first-gene-therapy-for-pediatric-leukemia</link><guid isPermaLink="true">http://direct.ecency.com/health/@etcmike/fda-approves-first-gene-therapy-for-pediatric-leukemia</guid><category><![CDATA[health]]></category><dc:creator><![CDATA[etcmike]]></dc:creator><pubDate>Fri, 01 Sep 2017 20:45:21 GMT</pubDate><enclosure url="https://images.ecency.com/p/3q52Dkr5nBe4UvtLzp7oxsb33UzD2GZcY984e2AhyGRfjDE9bziFMtaKokfTJpqSXPPiN92hBammx?format=match&amp;mode=fit" length="0" type="false"/></item></channel></rss>